首页 › 基金 › Ikarian Capital, LLC › SLS

Ikarian Capital, LLC 对 SLS 的持仓历史

SELLAS LIFE SCIENCES GROUP I · 医疗保健

Ikarian Capital, LLC 在 Q3 2026 的 13F 申报中披露持有 SLS(SELLAS LIFE SCIENCES GROUP I)354,700 股,市值约 US$4.4M,约占其申报组合的 0.64%,在其申报持仓中市值排名第 42 位。 Ikarian Capital, LLC 最近 2 个申报季度中有 2 个季度披露了 SLS 持仓,最早可追溯至 Q2 2026。

最新持仓 (Q3 2026)354.70K 股
申报持仓市值$4.37M
组合权重0.64%
首次申报Q2 2026
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Ikarian Capital, LLC 对 SLS 的持仓演变

Ikarian Capital, LLC 于 Q2 2026 首次披露 SLS 持仓:354,700 股(约 US$5.2M)。 在 2 次申报中,Ikarian Capital, LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 354,700 股、市值约 US$4.4M。

逐季持仓明细

季度股数金额变化
Q2 2026 354.70K $5.24M 新进
Q3 2026 354.70K $4.37M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 SLS 与 13F 数据

SLS(SELLAS LIFE SCIENCES GROUP I)属于医疗保健行业。我们追踪的基金中还有 96 只申报持有 SLS,申报仓位最大的包括:Anson Funds Management LP (US$38.2M), PERCEPTIVE ADVISORS LLC (US$30.8M), DAGCO, INC. (US$16.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SLS 的基金

查看 SLS 的全部基金持有人 →

常见问题

How long has Ikarian Capital, LLC held SLS?

Ikarian Capital, LLC has disclosed SLS holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Ikarian Capital, LLC's current position in SLS?

As of Q3 2026, Ikarian Capital, LLC holds 354.70K shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $4.37M, representing 0.64% of its reported portfolio and ranking #42.

Has Ikarian Capital, LLC been buying or selling SLS?

In the latest 13F filing (Q3 2026), Ikarian Capital, LLC held unchanged its position in SLS.

Which other funds hold SLS?

Other major institutional holders of SLS include Anson Funds Management LP, PERCEPTIVE ADVISORS LLC, DAGCO, INC., among 96 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.